A multi-tenant agentic AI platform for genetic testing, clinical diagnostics, pharmacogenomics, and precision medicine. 12 agents.
12 autonomous AI agents working in real-time. Each agent is a domain expert — orchestrated and quality-scored.
Routes genomic queries across the agent mesh. Manages state, parallelism, and quality gates.
ACMG/AMP 5-tier classification with proprietary VIS (Variant Intelligence Score) across 8 evidence streams.
CPIC Level A/B interpretation. 300+ drug-gene pairs. Metabolizer phenotype prediction.
TMB, MSI, gene fusions, OncoKB Level 1-4 therapy matching. Companion diagnostics.
Six-dimension heuristic quality scoring (Groundedness, Accuracy, Reliability, Variance, Inference Cost, Safety). Scores are trend signals, not clinical validation. The open-source scorers are in the Apache-2.0 ARGUS-AI library.
Aether is the output-correction layer in this product. When an output scores below threshold it is revised and re-checked, with a bounded number of retries. It reduces errors; it does not guarantee correct output, and high-risk outputs still go to human review. Separate from the open-source ARGUS-AI scoring library.
Draft clinical reports with every claim cited; a qualified geneticist reviews and signs out each result. Configurable templates per lab/institution. PDF/FHIR/HL7.
PubMed RAG synthesis. Real-time evidence retrieval with citation graphs and relevance scoring.
ChEMBL/AlphaFold drug target validation. ADMET prediction. Lead compound optimization.
Real-time NCT eligibility matching. Molecular profile to trial alignment across 400K+ active trials.
Automated VCF ingestion, normalization, annotation, and quality filtering. Multi-format support.
Designed around PHI encryption, audit logging, role-based access and per-tenant key isolation, configurable per deployment.
7 curated knowledge bases powering evidence-grounded interpretation. Every clinical assertion is traceable.
Production-ready across 9 clinical specialties. Each domain has specialized agent configurations and validated interpretation pipelines.
Comprehensive germline cancer risk assessment with multi-gene panel interpretation and cascade testing guidance.
Inherited cardiac conditions including cardiomyopathies, channelopathies, and familial hypercholesterolemia.
WES/WGS analysis with trio support, RNA-Seq integration, and phenotype-driven variant prioritization.
CPIC Level A/B drug-gene interaction reporting with metabolizer phenotype prediction and prescribing guidance.
Tumor profiling with actionable therapy matching, biomarker quantification, and clinical trial eligibility.
NIPT interpretation, chromosomal microarray analysis, and newborn screening follow-up.
Genetic testing for epilepsy, intellectual disability, autism spectrum, and neurodegenerative conditions.
AI-powered target validation, ADMET prediction, and lead compound optimization using ChEMBL and AlphaFold.
Real-time molecular profile to NCT trial matching across 400K+ active studies worldwide.
Native connectors for the genomics and healthcare ecosystem. Deploy on day one.
Bidirectional FHIR R4 integration with major EHR and laboratory information management systems.
Direct VCF ingestion from all major sequencing platforms and bioinformatics pipelines.
Any-cloud deployment with Kubernetes orchestration. On-prem, hybrid, and sovereign cloud support.
Export genomic intelligence to your analytics stack. Real-time streaming and batch modes.
Production-grade, cloud-native, multi-tenant. Built for healthcare scale and regulatory compliance.
FastAPI backend with async agent mesh. Parallel execution, state management, and configurable quality gates.
Real-time genomic analysis dashboard with interactive variant browsers, quality metrics, and report generation.
PostgreSQL with row-level security for multi-tenancy. Redis caching. Kafka event streaming. Qdrant vector DB for RAG.
Designed to support HIPAA safeguards: PHI encryption, 7-year audit retention, per-tenant key isolation. A SOC 2 audit can be engaged as part of a customer deployment.
GenomixIQ is engineered from day one for strategic integration — whether scaling as a standalone product, raising strategic capital, or positioning for acquisition by genomics leaders.
500+ tenant capacity with complete data isolation, per-tenant KMS encryption, and configurable agent pipelines per institution.
Provisional patent filed on the VIS Algorithm and Molecular Agent Mesh topology. The G-ARVIS scorers are available as the open-source ARGUS-AI library (Apache-2.0).
Clinical genomics, DTC testing, pharma R&D, and precision medicine. GenomixIQ addresses the fastest-growing AI segment in life sciences.
Not a single-use tool. GenomixIQ serves hereditary cancer, cardiology, rare disease, PGx, somatic oncology, prenatal, neuro, drug discovery, and clinical trials.
Encryption, audit logging and access control designed to support HIPAA, with business associate agreement terms agreed per customer deployment. Controls are configurable per deployment, and I support implementation and evidence gathering with your security and compliance team. A SOC 2 or similar audit can be engaged as part of a customer deployment. Certification is established by your own programme and auditors. FDA 21 CFR Part 11 is on the roadmap.
12 specialized agents, 7 curated knowledge bases, and quality scoring on every output. Performance compounds with scale.
Walk through a live simulation of variant analysis, agent orchestration, clinical report generation, and quality scoring. No signup required.
Launch Interactive DemoGenomixIQ is available for enterprise deployment, strategic investment, partnership, and acquisition conversations.